A greater abundance of CD8+ TILs was found in KRAS-mutant tumors (P = 0.006; Figure 4B), which was confirmed by IHC analyses of CD8+ TILs in 629 resected NSCLC specimens. This evidence concerns the gene KRAS and non-small cell lung carcinoma.